Anti-retinoic Acid Monoclonal Antibody Localizes All-trans-retinoic Acid in Target Cells and Blocks Normal Development in Early Quail Embryo

69Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Avian cardiovascular development is vitamin A-dependent, and retinoic acid has been suggested to be active in this important developmental event. We report here that a monoclonal antibody against all-trans-retinoic acid blocks normal embryonic development in the quail causing cardiovascular abnormalities typical of avian vitamin A deficiency. In whole-mount preparations of stage 5 normal quail embryos the fluorescence associated with the anti-retinoic acid monoclonal antibody localizes in Hensen's node and in caudal area. In stage 7-8 embryos fluorescence localizes in heart-forming areas as well as in head mesenchyme, in Hensen's node, in nephrotome, and in caudal area. These studies are the first to localize endogenous all-trans-retinoic acid during very early stages of normal avian development. We propose that all-trans-retinoic acid is biosynthesized in its target cells during early avian embryo-genesis and that the availability of this signal molecule is spatiotemporally regulated. We conclude that all-trans-retinoic acid or a closely related metabolite is the physiological form of vitamin A required for normal cardiovascular development and for other very early developmental events in the quail embryo. © 1995 by Academic Press, Inc.

Cite

CITATION STYLE

APA

Twal, W., Roze, L., & Zile, M. H. (1995). Anti-retinoic Acid Monoclonal Antibody Localizes All-trans-retinoic Acid in Target Cells and Blocks Normal Development in Early Quail Embryo. Developmental Biology, 168(2), 225–234. https://doi.org/10.1006/dbio.1995.1075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free